Measles, mumps, and rubella antibodies in children 5–6 years after immunization: effect of vaccine type and age at vaccination
- 1 January 1995
- Vol. 13 (16), 1611-1616
- https://doi.org/10.1016/0264-410x(95)00098-l
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Measles vaccine efficacy during an outbreak in a highly vaccinated population: Incremental increase in protection with age at vaccination up to 18 monthsEpidemiology and Infection, 1995
- Sustained Transmission of Mumps in a Highly Vaccinated Population: Assessment of Primary Vaccine Failure and Waning Vaccine-Induced ImmunityThe Journal of Infectious Diseases, 1994
- Reduced measles immunity in infants in a well-vaccinated populationThe Pediatric Infectious Disease Journal, 1992
- Measles Antibody: Reevaluation of Protective TitersThe Journal of Infectious Diseases, 1990
- Duration of live measles vaccine-induced immunityThe Pediatric Infectious Disease Journal, 1990
- The role of secondary vaccine failures in measles outbreaks.American Journal of Public Health, 1989
- Measles Outbreak in a Fully Immunized Secondary-School PopulationNew England Journal of Medicine, 1987
- The Plaque-Neutralization Test as a Measure of Prior Exposure to Measles VirusThe Journal of Infectious Diseases, 1987
- A controlled trial for evaluating two live attenuated mumps‐measles vaccines (Urabe Am 9‐Schwarz and Jeryl Lynn‐Moraten) in young childrenJournal of Medical Virology, 1986
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977